id: alcohol_use_disorder_to_NEW:alcohol_associated_liver_disease
name: Alcohol Use Disorder â†’ Alcohol-Associated Liver Disease
from_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Disorder
to_node:
  node_id: NEW:alcohol_associated_liver_disease
  node_name: Alcohol-Associated Liver Disease
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic excessive alcohol consumption in individuals with AUD leads to sustained hepatotoxic
  exposure'
- 'Step 2: Alcohol metabolism produces acetaldehyde and reactive oxygen species causing hepatocyte damage'
- 'Step 3: Repeated liver injury triggers inflammatory responses and fibrotic changes'
- 'Step 4: Progressive liver damage manifests as fatty liver, hepatitis, fibrosis, or cirrhosis'
evidence:
  quality_rating: A
  n_studies: 35
  primary_citation: 'Sachin Amonker et al. 2023. "Prevalence of alcohol-associated liver disease: a systematic
    review and meta-analysis." https://doi.org/10.1097/HC9.0000000000000133'
  supporting_citations:
  - Additional citations require full-text access - this meta-analysis synthesized 35 studies reporting
    on 513,278 persons
  - Studies included populations from unselected general populations, primary care, and AUD treatment
    settings
  - Original studies used universal testing processes including imaging and biomarkers for liver disease
    detection
  doi: 10.1097/HC9.0000000000000133
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: This systematic review and meta-analysis of 35 studies found that alcohol-associated liver
  disease prevalence is dramatically higher among individuals with alcohol use disorder (51.0%) compared
  to general populations (3.5%) and primary care settings (2.6%), demonstrating the strong biological
  link between sustained alcohol consumption and liver pathology.
quantitative_effects:
  effect_size:
    value: 51.0
    type: percentage_change
    ci_lower: 11.1
    ci_upper: 89.3
  sample_size: 513278
moderators:
- name: healthcare_setting
  direction: strengthens
  strength: strong
  description: Prevalence varies dramatically by setting - 51% in AUD populations vs 3.5% in unselected
    populations vs 2.6% in primary care
structural_competency:
  equity_implications: While this mechanism documents the biological pathway from AUD to liver disease,
    structural factors including alcohol marketing, outlet density, pricing policies, and treatment access
    shape who develops AUD and who receives early intervention. The dramatic difference in prevalence
    between settings suggests opportunities for targeted case-finding in populations with AUD, which requires
    adequate funding and capacity for substance use treatment systems.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.418403'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
